Statements of operations - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2019	Oct. 31, 2018	Oct. 31, 2019	Oct. 31, 2018
Revenue:
Revenues	$ 32,843	$ 24,756	$ 91,968	$ 73,406
Expenses:
Cost of revenue (excluding depreciation and amortization)	4,388	3,805	12,594	10,632
Payment processing expense	6,902	5,393	20,952	16,309
Sales and marketing	8,348	7,195	24,170	19,971
Research and development	4,774	3,856	13,762	10,144
General and administrative	7,184	4,540	20,849	14,118
Depreciation	2,153	1,966	6,444	5,515
Amortization	1,325	1,037	3,823	2,912
Total expenses	35,074	27,792	102,594	79,601
Operating loss	(2,231)	(3,036)	(10,626)	(6,195)
Other income (expense)	77	203	(740)	167
Change in fair value of warrant liability	0	(611)	(3,307)	(1,496)
Interest income (expense)	(219)	(728)	(1,769)	(2,459)
Total other income (expense)	(142)	(1,136)	(5,816)	(3,788)
Loss before provision for income taxes	(2,373)	(4,172)	(16,442)	(9,983)
Provision for income taxes	(64)	0	(183)	0
Net loss	(2,437)	(4,172)	(16,625)	(9,983)
Preferred stock dividend paid	0	0	(14,955)	0
Accretion of redeemable preferred stock	0	(9,236)	(56,175)	(20,962)
Net loss attributable to common stockholders, basic and diluted	$ (2,437)	$ (13,408)	$ (87,755)	$ (30,945)
Net loss per share attributable to common stockholders, basic and diluted	$ (0.07)	$ (7.02)	$ (5.85)	$ (26.30)
Weighted-average common shares outstanding, basic and diluted	35,790,951	1,909,858	15,007,247	1,176,833
Subscription And Related Services [Member]
Revenue:
Revenues	$ 14,606	$ 10,929	$ 41,292	$ 31,391
Payment Processing Fees [Member]
Revenue:
Revenues	11,559	9,073	34,781	27,478
Life Sciences [Member]
Revenue:
Revenues	$ 6,678	$ 4,754	$ 15,895	$ 14,537